BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


February Archive 2005 - have your press release here?

Psoriasis: Biologics hope to reach 8mill undiagnosed sufferers

Blockbuster brands generate generic goals

Cobra signs long term deal with Neovacs SA to supply Phase I clinical trial material for a novel protein active immunization therapy-TNFa Kinoid

Dr. Steven St. Peter Joins Atugen’s Supervisory Board

SYMPHOGEN STRENGTHENS PATENT POSITION IN POLYCLONAL ANTIBODIES

NextGen Sciences receives the Frost & Sullivan Technology Leadership Award for 2005

BioCentral Investors’ Day - Unique growth opportunities for venture capital investors

ROLF STAHEL APPOINTED AS CHAIRMAN OF POWDERMED

MNLpharma Strengthens Team

Emerging treatments for inflammatory bowel disease

Migraine treatment - a financial headache

New trial of HIV/AIDS vaccine incorporates Cobra technology

OXFORD BIOMEDICA AND VIRAGEN REPORT PROGRESS IN AVIAN TRANSGENICS BIOMANUFACTURING

Sigma-Aldrich to Acquire Proligo Group to Strengthen Genomics Research Tools Portfolio

Trends in drug patent expirations - new features from thinkPharm

Top 7 Reasons To Attend IBC’s IBC’s Regulatory Submission Standards Conference

Grant Instruments - for precision temperature control you can rely on

Analytical Method Validation Case Studies of Practical Solutions for Various Assay Types and Stages of Drug Development

InterMune's hepatitis strategy gets the right response

Innovatives & supportive care way forward for Cancer drugs

New ChemiGeniusXE 3 The Highest Resolution Multi-Purpose Image Analyser Available

JPK Instruments AG - More space for Nanobiotechnology

Sigma-Aldrich Offers Instant Savings with Its New Lab Start-Up Program

BioImpact: Biotechnology for patients

Industrialists call for a real industrial and financial policy for biotechnologies in Europe

A Possible Mechanism for the "Broken Heart" Syndrome

Q Chip - Microfluidics Venture Motors Ahead

CATACHEM, INC. is pleased to announce the addition of Fructosamine (glycated proteins) to the DiscretePak™ and VetSpec™ line of diagnostic chemistry reagents.

CATACHEM, INC. tiene el gusto de anunciar la adición de fructosamina (proteínas glucadas) a la línea de los reactivos químicos clínicos de diagnostico, DiscretePak™ y VetSpec™.

Catachem is pleased to announce the availability of our VetSpec™ diagnostic test reagents for the COBAS MIRA™, discrete, random access analyzer.

Catachem se siente muy contenta de anunciar la disponibilidad de sus reactivos de diagnóstico DiscretePak™

New Web Site for Microscopists Offers Simple Guide to Tools for Improving Digital Imaging

Cobra extends its agreement with Oncolytics Biotech Inc. to provide long term manufacture of REOLYSIN®

BIO Deutschland Calls on Amendment of the Stem-Cell Act Stem Cells: Yes to Research, but no Therapy?

How Employers and Commercial Landlords Can Maintain a Mold-Safe Workplace

ATUGEN AND ASINEX ANNOUNCE DISCOVERY PROGRAM FOR NOVEL PROTEIN KINASE TARGET

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) GROUP PLC

Progress in the treatment of peripheral arterial disease (PAD)

Eisai's retinoic acid (RAR)-alpha receptor agonist as a candidate therapy for the treatment of lupus nephritis

Asthma: alternative anti-inflammatory agents needed for patient subgroup

Biacore launches new generation system for protein interaction analysis

ExonHit Launches SpliceArray Service With GPCR And Ion Channel Microarrays Using Agilent Technologies' Microarray Platform

Genetix launches breakthrough technology for the development of biopharmaceuticals

OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT

New Agonist Antagonist Optimal Ratio Combinations as a Potentially Safer Class of Pharmaceutical Drugs

The Overlooked Problem of Drug-Receptor Desensitization

Screen Validates MNLpharma’s Compound Activity

HIV vaccines: education key to partial efficacy success

Migraine treatment financial headache for national healthcare systems

Biomedical Photometrics Launches TISSUEscope

SYMPHOGEN A/S NAMED BY TORNADO INSIDER AMONG EUROPE'S TOP 100 PRIVATE TECH COMPANIES

CATACHEM, INC. announces the addition of Fructosamine (glycated proteins) to the DiscretePak™ and VetSpec™ line of diagnostic chemistry reagents

Catachem announces availability of VetSpec™ diagnostic test products

NEURO3d NAMED BY TORNADO INSIDER AMONG EUROPE’S TOP 100 PRIVATE TECH COMPANIES

IntegraGen to take a leading role in unraveling the genetics of obesity in a €14.5M EU funded program

Professor Cy Stein Joins Atugen’s Scientific Advisory Board

Chronic hepatitis B and C: a chronic lack of effective treatment

Strategic alliances – what’s the big deal?

New Application of ChemiGenius2 To Analyse Large Proteins Associated with Type 2 Diabetes

ESBATech hires CFO and Director of Preclinical Development

Automated Colony Counters Help Monitor Air Quality To Provide a Healthier Living Environment

New Ant Species Identified by Harvard University Using Syncroscopy’s Auto-Montage Software

SyncroScan Improves Imaging of Human Hip Bones At Major European Bone Research Unit

Incomplete control of HbA1c levels is the major drawback to current non-insulin antidiabetics

Oxford Immunotec Appoints Stuart Rose as Global Marketing Director

Genetix Limited launches QPExpression – new automated bacterial protein expression system

Agilent Technologies Expands Custom Microarray Offering with Industry's First Shared-Design Program

Malvern launches new web resource for protein researchers

SCYNEXIS Europe appoints Geoffrey Sheppard as Head of Radiochemistry

Scancell Signs New Agreement with Biovation to DeImmunise SC101

Details of £4.3 million Agreement Announced on 22 September 2004 Partner : Serono - Human Growth Hormone : Drug for Needle-free System

'Silent killer' osteoporosis quietly on the increase

TiGenix completes recruitment of multinational Phase III clinical trial for cartilage repair

Shantha Biotech Introduces Shanvac-B in BD Uniject™

SENEXIS APPOINTS CHRIS MOYSES AS CHAIRMAN AND DAVID SCOPES AS CHIEF SCIENTIFIC OFFICER

Morphochem enters Research Alliance with Alcon to develop novel ophthalmic compounds

Paradigm Therapeutics Ltd acquires Amedis Pharmaceuticals Ltd

SOCS1 silencing dramatically increases the anti-cancer efficacy of dendritic cell vaccines

Agilent Technologies Expands Microarray Platform to Address New Array-Based Genomics, Disease Research Applications

Agilent Technologies Acquires Computational Biology Corp., Pioneer in Gene Regulation Analysis

Agilent Technologies Announces Breakthrough for Cancer Researchers Studying Chromosomal Changes

DOW PHARMACEUTICAL SCIENCES ACQUIRES BIOSKIN, EUROPE’S LEADING DERMATOLOGY CRO

OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT WITH BIOGEN IDEC

Sorafenib offers hope in the battle for liver cancer survival

IntegraChips™ to help develop “identity cards” for cancer tumours

Peakdale Molecular appoints Glenn Killingworth to strengthen US Sales

OXFORD BIOMEDICA PUBLISHES PRECLINICAL EFFICACY RESULTS WITH ITS PRODUCT CANDIDATE SMN1-G FOR SPINAL MUSCULAR ATROPHY

$42.6 Million Five-Year Grant From Gates Foundation for Antimalarial Drug Brings Together Unique Collaboration of Biotech, Academia and Nonprofit Pharma

BioNewsCast Press Release Service 2005 Archive

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.